% Ratio of Prescribing of Antidepressant, Hypnotic and Antipsychotic Drugs in General Practice in England.

Slides:

Advertisements

Similar presentations

Prof Graeme Henderson Department of Pharmacology C32 Medical Sciences Building Anticholinergics Opioids Benzodiazepines and.

Advertisements

Carol Coupland Paula Dhiman Tony Arthur Richard Morriss Julia Hippisley-Cox University of Nottingham Garry Barton University of East Anglia Antidepressant.

Drug List 4 Quiz Review □ A patient comes to the doctor with symptoms of Restless Leg Syndrome. □ Which of these might be prescribed? a.Cogentin.

Guy Brookes Leeds PFT.  Antipsychotic Medication  Antidepressant Medication  Mood Stabilisers  What does the Evidence mean?

DUR Board Meeting March 12, 2008 West Virginia Department of Health and Human Resources Bureau for Medical Services Drug Utilization Review Board.

PACKAGING OF MEDICINES AND CHILDREN SAFETY Accident data from Belgium Dr Martine MOSTIN.

Relative toxicity of traditional versus atypical antipsychotics in deliberate self poisoning M A Downes, G K Isbister, D Sibbritt, I M Whyte, A H Dawson.

Newer Psychotropic Medications David P. Kraft, MD, MPH Region I Mental Health Consultant Region 1 Health and Wellness Conference San Juan, Puerto Rico.

Chapter 3 Biological Basis for Understanding Psychiatric Disorders and Treatments Copyright © 2014, 2010, 2006 by Saunders, an imprint of Elsevier Inc.

General Management principles- Investigations & Treatment Modalities Dr Alok Rana Consultant Old Age Psychiatrist.

Trends in Usage of Non-Opioid Analgesics in General Practice in England © Copyright NHSBSA 2008.

1 These slides should be used in conjunction with the accompanying notes Hypnotics.

Trends in Prescribing of and Spending on Digoxin in General Practice in England © Copyright NHSBSA 2009.

1 Pharmaceutical Descriptive Analysis Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group July 2007.

Neurotransmission and drug action in the central nervous system   Neuroleptics  Anton Kohút.

1 Deaths from antidepressants in England and Wales 1993 to 2000: analysis of a national database of drug-related poisoning deaths Allan Baker, UK Office.

Marcie Hall, M.D. Department of Child and Adolescent Psychiatry University Hospitals Case Medical Center Autism Summit October 10, 2008 Medication Use.

Psychopharmacology – A brief introduction. Objectives Review general categories of psychiatric disorders Review general categories of psychiatric disorders.

Bipolar I Disorder Treatment. Therapeutic Goals Relief of immediate symptoms Improvement of patient’s well-being Elimination of stressors Combined pharmacotherapy.

Trends in Spending on Selective Beta 2 Agonists in General Practice in England.

Pharmacological Management. Only symptomatic treatment, there is no cure. Acetylcholinesterase inhibitors - Only for mild to moderate dementia –Donepezil.

+ Finding Balance: Preventing Medication Related Falls Through Appropriate Medication Use Chanel F. Agness, PharmD, Certified Geriatric Pharmacist

Trends in Prescribing of Selected Alpha-Blockers in General Practice in England © Copyright NHSBSA 2008.

Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 22 Drugs Affecting the Central Nervous System.

Trends in Prescribing of Sodium Chloride Irrigation Solutions in General Practice in England © Copyright NHSBSA 2008.

Stuttering and Medications City of Chicago NSA Chapter March 26, 2015.

PSYCHIATRIC DRUGS Chapter 13. Psychiatric Drugs  Treat mood, cognition, and behavioral disturbances associated with psychological disorders  Psychotropic.

Maryam Tabatabaee M.D Assistant professor of psychiatry.

Drugs Used in Autism and Other Neurological diseases.

% Ratio of Prescribing of Antidepressant, Hypnotic and Antipsychotic Drugs in General Practice in England © Copyright NHSBSA 2009.

Treating Mental Illness Bittu Majmudar September 25, 2007 Neuroethics.

Buprenorphine Treatment for Opioid Dependence CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for.

Pie Chart Showing the Breakdown of Gastro-intestinal Prescribing in General Practice in England (July June 2008 ) © Copyright NHSBSA 2008.

Practice pharmacology, medical students III.yr. November 2013

Psychotropic Medication Management on Center David P. Kraft, MD, MPH Region I Mental Health Consultant National Health and Wellness Conference Orlando,

Variations in anxiolytic and hypnotic prescribing by GPs: a cross-sectional analysis using data from the UK Quality and Outcomes Framework by Zoi Tsimtsiou,

Trends in Spending on Selective Beta 2 Agonists in General Practice in England © Copyright NHSBSA 2009.

Nervous System Pharmacology Review 26 December :45 AM.

Psychiatric Medications: Interactions Chitra Malur MD Asst. Chief of Service Dept. of Psychiatry UMDNJ.

The Latest Prescription Trends for Controlled Prescription Drugs

3 Revolutions in Psychology - Psychiatry Psychotherapeutic Drugs.

Prescribing in Dementia. Plan What to prescribe? When to prescribe? How to review? Who to review?

Inside Maine’s Medicine Cabinet. Inside Maine’s Medicine Cabinet: Analysis of the Maine Prescription Monitoring Program, Christina Holt, MD,

John Tsuang, M.D., M.S. Associate Clinical Professor Department of Psychiatry, University of California Los Angeles Director of Dual Diagnostic Treatment.

CLINICAL PHARMACOLOGY OF DRUGS AFFECTING THE NERVOUS SYSTEM.

News You Can Use… Phillip Transou, PharmD Candidate Pete Koval, PharmD Cone Health Family Medicine June, 2016.

Drugs Used in Autism and Other Neurological diseases Dr. Yieldez Bassiouni.

INTRODUCTORY MENTAL HEALTH NURSING Donna M. Womble 2005.

1 Future Spending for Prescription Drugs Used for Mental Health and Substance Use Disorders: Does the Past Portend the Future? Linda Simoni-Wastila, RPh,

Quetiapine Fumarate Quetiapine Fumarate is an atypical antipsychotic used in the treatment of schizophrenia, bipolar I mania, bipolar II depression, bipolar.

Pharmacological management of delirium

Psychopharmacology of Autism Spectrum Disorder

Dementia and Medication Considerations

Ch. 13: Biomedical Therapy: Biological Approaches to Treatment

Barbiturates Meprobamate Paralehyde Chloral hydrate

Brief Overview of Common Psychotropic Medications --and--

Psychiatric Drugs Chapter 13.

Medication Effects That May Impair Driving Ability

Drug-induced dyskinesias

National findings from the Illicit Drug Reporting System

Chapter 9: Community Pharmacy

CHAPTER 21 Drugs and other physical treatments

Polypharmacy Pharmacist Consultant Liz Butterfield FRPharmS

Trends in diagnosis and treatment for people with dementia in the UK from 2005 to 2015: a longitudinal retrospective cohort study Katherine Donegan,

Depression in the Elderly

The prescribing of methadone and other opioids to addicts: national survey of GPs in England and Wales by John Strang, Janie Sheridan, Claire Hunt, Bethanne.

by Zoi Tsimtsiou, Mark Ashworth, and Roger Jones

Dr James Ovens Consultant Psychiatrist Tandridge CMHRS

Nervous System Pharmacology Review

Presentation transcript:

% Ratio of Prescribing of Antidepressant, Hypnotic and Antipsychotic Drugs in General Practice in England

% Ratio of Spending on Antidepressant, Hypnotic and Antipsychotic Drugs in General Practice in England

Trends in Prescribing of Hypnotics in General Practice in England

Trends in Spending on Hypnotics in General Practice in England

Quantities of "Z" drugs (Zaleplon, Zolpidem & Zopiclone) Prescribed in General Practice in England (Quarter to June 2008)

Quantities of Selected Hypnotics (Tabs/Caps) Prescribed in General Practice in England (Quarter to June 2008)

% of Prescriptions for Selected Hypnotics (Tabs/Caps) in General Practice in England for Defined Quantities (Quarter to June 2008)

Trends in Prescribing of Anxiolytics in General Practice in England

Trends in Spending on Anxiolytics in General Practice in England

Trends in Prescribing of Antipsychotic Drugs (BNF 4.2.1) in General Practice in England

Trends in Spending on Antipsychotic Drugs (BNF 4.2.1) in General Practice in England

Trends in Prescribing of "Typical" Antipsychotics in General Practice in England

Trends in Spending on "Typical" Antipsychotics in General Practice in England

Trends in Prescribing of "Atypical" Antipsychotics in General Practice in England

Trends in Spending on "Atypical" Antipsychotics in General Practice in England

Trends in Prescribing of Olanzapine Tablets by Strength in General Practice in England

Trends in Prescribing of Quetiapine by Strength in General Practice in England

Trends in Prescribing of Risperidone Tablets by Strength in General Practice in England

Trends in Prescribing of and Spending on Valproic Acid (Depakote®) in General Practice in England

Trends in Prescribing of and Spending on Lithium in General Practice in England

Trends in Prescribing of Antidepressants in General Practice in England

Trends in Spending on Antidepressants in General Practice in England

Trends in Prescribing of Tricyclic and related antidepressants in General Practice in England

Trends in Spending on Tricyclic and related antidepressants in General Practice in England

Trends in Prescribing of SSRIs in General Practice in England

Trends in Spending on SSRIs in General Practice in England

Trends in Prescribing of Other Antidepressant drugs (BNF 4.3.4) in General Practice in England

Trends in Spending on Other Antidepressant drugs (BNF 4.3.4) in General Practice in England

Trends in Prescribing of and Spending on Atomoxetine in General Practice in England

Trends in Prescribing of and Spending on Methylphenidate in General Practice in England

Trends in Prescribing of Methylphenidate Preparations in General Practice in England

Trends in Spending on Methylphenidate Preparations in General Practice in England

Trends in Prescribing of Methadone in General Practice in England

Trends in Spending on Methadone in General Practice in England

Trends in Prescribing of Methadone (Excluding Liquid Formulations) in General Practice in England

Trends in Prescribing of Older Antiepileptic Drugs in General Practice in England

Trends in Spending on Older Antiepileptic Drugs in General Practice in England

Trends in Prescribing of Newer Antiepileptic Drugs in General Practice in England

Trends in Spending on Newer Antiepileptic Drugs in General Practice in England

Trends in Prescribing of Co-beneldopa and Co-careldopa in General Practice in England

Trends in Spending on Co-beneldopa and Co-careldopa in General Practice in England

Trends in Prescribing of Other Dopaminergic Drugs used in Parkinsonism in General Practice in England

Trends in Spending on Other Dopaminergic Drugs used in Parkinsonism in General Practice in England

Trends in Prescribing of Antimuscarinic Drugs in General Practice in England

Trends in Spending on Antimuscarinic Drugs in General Practice in England

Trends in Prescribing of and Spending on Buprenorphine and Buprenorphine / Naloxone (BNF 4.10 Opioid Dependence) in General Practice in England

Trends in Prescribing of and Spending on Lofexidine in General Practice in England

Trends in Prescribing of and Spending on Naltrexone in General Practice in England

Trends in Prescribing of Drugs for Dementia in General Practice in England

Trends in Spending on Drugs for Dementia in General Practice in England

Trends in Prescribing of Melatonin in General Practice in England

Trends in Spending on Melatonin in General Practice in England

Trends in Instalment Dispensing Forms in General Practice in England